Murphy Andrew J

Co-Chief Scientific Officer at REGN

Sold, on record
$62.4M
Dollars the filings state
Form 4 sales
15
Latest Nov 17, 2026
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • REGNREGENERON PHARMACEUTICALS, INC.Co-Chief Scientific Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale REGNRoutine
    Nov 14, 2023 2023

    Sold 6,492 shares at $799.17 ($5.2M)

    Murphy Andrew J, EVP Research

    10b5-1 planSold 9.8% of holdings ($52.7M position)59,421 shares left1.8x usual sizeFollows a Form 144Filing

  2. 2 Form 144 notice REGNNotice
    Dec 5, 2023 +21 days

    Filed to sell 6,536 shares ($5.3M)

    Murphy Andrew J, Officer

    10b5-1 plan1.8x usual sizeFiling

  3. 3 Form 4 sale REGNRoutine
    Dec 5, 2023 same day

    Sold 6,536 shares at $817.44 ($5.3M)

    Murphy Andrew J, EVP Research

    10b5-1 planSold 9.9% of holdings ($53.9M position)59,421 shares left1.8x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice REGNNotice
    Mar 14, 2024 +100 days

    Filed to sell 5,783 shares ($5.6M)

    Murphy Andrew J, Officer

    10b5-1 plan1.6x usual sizeFiling

  5. 5 Form 4 sale REGNRoutine
    Mar 14, 2024 same day

    Sold 5,783 shares at $956.47 ($5.5M)

    Murphy Andrew J, EVP Research

    10b5-1 planSold 10.7% of holdings ($51.7M position)48,306 shares left1.6x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice REGNNotice
    Aug 14, 2024 +153 days

    Filed to sell 6,363 shares ($7.3M)

    Murphy Andrew J, Officer

    10b5-1 plan1.1x usual sizeFiling

  7. 7 Form 4 sale REGNRoutine
    Aug 14, 2024 same day

    Sold 6,363 shares at $1,153.15 ($7.3M)

    Murphy Andrew J, EVP Research

    10b5-1 planSold 11.6% of holdings ($63M position)48,306 shares left1.1x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale REGNRoutine
    Nov 17, 2026 +825 days

    Sold 5,011 shares at $957.76 ($4.8M)

    Murphy Andrew J, Co-Chief Scientific Officer

    10b5-1 planSold 9.7% of holdings ($49.6M position)46,779 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (19)

Form 144 notices and Form 4 sales by Murphy Andrew J
Source
Nov 17, 2026Nov 18, 2026REGNCo-Chief Scientific OfficerForm 4 sale5,011$4.8M9.7%RoutineSEC
Aug 14, 2024Aug 15, 2024REGNEVP ResearchForm 4 sale6,363$7.3M11.6%RoutineSEC
Aug 14, 2024Aug 14, 2024REGNOfficerForm 144 notice6,363$7.3MNoticeSEC
Mar 14, 2024Mar 15, 2024REGNEVP ResearchForm 4 sale5,783$5.5M10.7%RoutineSEC
Mar 14, 2024Mar 14, 2024REGNOfficerForm 144 notice5,783$5.6MNoticeSEC
Dec 5, 2023Dec 6, 2023REGNEVP ResearchForm 4 sale6,536$5.3M9.9%RoutineSEC
Dec 5, 2023Dec 5, 2023REGNOfficerForm 144 notice6,536$5.3MNoticeSEC
Nov 14, 2023Nov 15, 2023REGNEVP ResearchForm 4 sale6,492$5.2M9.8%RoutineSEC
Nov 14, 2023Nov 14, 2023REGNOfficerForm 144 notice6,492$5.2MNoticeSEC
Nov 15, 2022Nov 16, 2022REGNEVP ResearchForm 4 sale3,720$2.7M6.1%Plan not statedSEC
Aug 16, 2022Aug 17, 2022REGNEVP ResearchForm 4 sale3,513$2.3M5.7%Plan not statedSEC
May 17, 2022May 18, 2022REGNEVP ResearchForm 4 sale3,543$2.4M5.7%Plan not statedSEC
Feb 15, 2022Feb 16, 2022REGNEVP ResearchForm 4 sale3,540$2.2M5.7%Plan not statedSEC
Dec 10, 2021Dec 10, 2021REGNEVP ResearchForm 4 sale7,122$4.7M10.7%Plan not statedSEC
Nov 16, 2021Nov 17, 2021REGNEVP ResearchForm 4 sale7,167$4.6M11.4%Plan not statedSEC
Nov 17, 2020Nov 18, 2020REGNEVP ResearchForm 4 sale6,628$3.6M12.3%Plan not statedSEC
Jul 14, 2020Jul 15, 2020REGNEVP ResearchForm 4 sale2,380$1.5M5.4%Plan not statedSEC
Jul 14, 2020Jul 15, 2020REGNEVP ResearchForm 4 sale11,929$7.5M21.2%Plan not statedSEC
Jan 27, 2020Jan 28, 2020REGNEVP ResearchForm 4 sale8,000$2.7M13.8%Plan not statedSEC